Projects per year
Search results
-
Active
R6416CNR: Phase 1B/II study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients
Van Schaeybroeck, S. (PI), Johnston, P. (CoI), Kennedy, R. (CoI), Lawler, M. (CoI), Longley, D. (CoI), Salto-Tellez, M. (CoI) & Wilson, R. (CoI)
01/08/2013 → …
Project: Research
-
Finished
R1938CNR: Development of biomarkers for inhibitors of GRP78, the master regulator of the unfolded protein response, for poor prognostic colorectal cancer subgroups.
Van Schaeybroeck, S. (PI) & Kennedy, R. (CoI)
06/09/2018 → 30/09/2020
Project: Research
-
R1290CNR: Development of EGFR Targeted Camptothecin-Loaded Nanoparticles for Targeting Kras Wild-Type Colorectal Cancer
Longley, D. (PI), Scott, C. (CoI) & Van Schaeybroeck, S. (CoI)
01/08/2012 → 30/09/2014
Project: Research
-
R6383CNR: Apoptosis Modelling for Treatment Decisions in Colorectal Cancer
Van Schaeybroeck, S. (PI), Johnston, P. (CoI) & Longley, D. (CoI)
01/08/2012 → 31/10/2014
Project: Research